ZA753091B - 1h-tetrazole derivatives - Google Patents

1h-tetrazole derivatives

Info

Publication number
ZA753091B
ZA753091B ZA00753091A ZA753091A ZA753091B ZA 753091 B ZA753091 B ZA 753091B ZA 00753091 A ZA00753091 A ZA 00753091A ZA 753091 A ZA753091 A ZA 753091A ZA 753091 B ZA753091 B ZA 753091B
Authority
ZA
South Africa
Prior art keywords
tetrazole derivatives
tetrazole
derivatives
Prior art date
Application number
ZA00753091A
Other languages
English (en)
Inventor
T Oe
M Tsuruda
Original Assignee
Yoshitomi Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yoshitomi Pharmaceutical filed Critical Yoshitomi Pharmaceutical
Publication of ZA753091B publication Critical patent/ZA753091B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
ZA00753091A 1974-05-28 1975-05-13 1h-tetrazole derivatives ZA753091B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6063274A JPS5516432B2 (it) 1974-05-28 1974-05-28

Publications (1)

Publication Number Publication Date
ZA753091B true ZA753091B (en) 1976-04-28

Family

ID=13147870

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00753091A ZA753091B (en) 1974-05-28 1975-05-13 1h-tetrazole derivatives

Country Status (12)

Country Link
US (1) US4085111A (it)
JP (1) JPS5516432B2 (it)
AT (1) AT347946B (it)
BE (2) BE829474A (it)
CA (1) CA1046064A (it)
CH (1) CH605960A5 (it)
DE (1) DE2521980C2 (it)
FR (1) FR2279398A1 (it)
GB (1) GB1466493A (it)
NL (1) NL181408C (it)
SE (1) SE425739B (it)
ZA (1) ZA753091B (it)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52105197A (en) * 1976-03-01 1977-09-03 Yoshitomi Pharmaceut Ind Ltd 1h-terazole derivatives
JPS5825677B2 (ja) * 1977-09-26 1983-05-28 武田薬品工業株式会社 ３−テトラゾ−ル−１−アザキサントン誘導体およびその製造法
JPS56100719A (en) * 1980-01-17 1981-08-12 Yoshitomi Pharmaceut Ind Ltd Antirheumatic agent
WO1984001711A1 (en) * 1982-10-30 1984-05-10 Yoshitomi Pharmaceutical Hypotensives
FR2549831A1 (fr) * 1983-07-27 1985-02-01 Rhone Poulenc Agrochimie Nouveaux derives d'acides aryloxybenzoiques, et leur utilisation comme herbicides
US7320967B2 (en) * 2002-04-23 2008-01-22 L'oreal Cosmetic composition, method of cosmetic treatment and preparation of a composition for promoting the growth and/or preventing or delaying the loss of hair
FR2838641B1 (fr) * 2002-04-23 2005-12-23 Oreal Composition cosmetique, procede de traitement cosmetique et preparation d'une composition pour favoriser la pousse et/ou empecher ou retarder la chute des cheveux
CA2482711A1 (fr) * 2002-04-23 2003-11-06 L'oreal Composition cosmetique pour favoriser la pousse et/ou empecher ou retarder la chute des cheveux
CA2916653C (en) 2013-06-27 2017-07-18 Pfizer Inc. Heteroaromatic compounds and their use as dopamine d1 ligands

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2977372A (en) * 1958-04-09 1961-03-28 William G Finnegan Process for preparing substituted tetrazoles
US3536715A (en) * 1967-03-24 1970-10-27 Miles Lab 2-lower alkyl-5-(omega-(4-phenyl-1-piperazinyl) lower alkyl)-2h-tetrazoles
GB1362782A (en) * 1970-08-26 1974-08-07 Fisons Ltd Tetrazole derivatives
BE759292A (fr) * 1969-11-27 1971-05-24 Allen & Hanburys Ltd Derives de xanthone, leur preparation et leur emploi
GB1403487A (en) * 1972-07-21 1975-08-28 Yoshitomi Pharmaceutical Heterocyclic substituted alkanoic acids and derivatives
US3939173A (en) * 1972-09-06 1976-02-17 Burroughs Wellcome Co. Substituted carbonyl compounds
NL7403583A (it) * 1973-03-19 1974-09-23

Also Published As

Publication number Publication date
ATA402475A (de) 1978-06-15
CH605960A5 (it) 1978-10-13
BE829474A (fr) 1975-09-15
GB1466493A (en) 1977-03-09
JPS50151897A (it) 1975-12-06
JPS5516432B2 (it) 1980-05-01
SE7506058L (sv) 1975-12-01
NL7506210A (nl) 1975-12-02
AU8149875A (en) 1976-11-25
FR2279398A1 (fr) 1976-02-20
FR2279398B1 (it) 1980-02-15
US4085111A (en) 1978-04-18
SE425739B (sv) 1982-11-01
NL181408B (nl) 1987-03-16
NL181408C (nl) 1987-08-17
AT347946B (de) 1979-01-25
DE2521980C2 (de) 1985-08-22
DE2521980A1 (de) 1975-12-18
CA1046064A (en) 1979-01-09
BE888694Q (fr) 1981-08-28

Similar Documents

Publication Publication Date Title
PH11652A (en) Arloxphenylpropylamines derivatives
IL48592A0 (en) Novel 1-substituted-4-benzylpiperidine derivatives
IL48593A0 (en) Novel 1-substituted-4-benzylidenepiperidine derivatives
ZA753968B (en) Novel benzimidazolinone derivatives
IL46341A0 (en) Alpha-aryl-4-substituted piperidinoalkanol derivatives
GB1519811A (en) Thienothaiazine derivatives
PH12312A (en) Thienothiazine derivatives
ZA757828B (en) 2-methoxy-benzamide derivatives
AU1038176A (en) 4-arylpiperidine derivatives
PH13481A (en) Rifanycin derivative
GB1484049A (en) 3-alkoxy-pyrazine-2-carboxamide derivatives
AU7921975A (en) Hexahydro-alpha-carboline derivatives
GB1521320A (en) Quinolisidine derivatives
ZA753091B (en) 1h-tetrazole derivatives
CY997A (en) Sulphonamido derivatives
ZA753315B (en) Oxacyclohexane derivatives
ZA754602B (en) Antiboiotic a2041 derivative
PH12265A (en) Benzo-bicyclononene derivatives
ZA755543B (en) Thiomethylcephem derivatives
ZA756893B (en) Phenyl-pyridylamine derivatives
ZA753299B (en) Amidino-hydrazone derivatives
AU8332175A (en) New hydroxyphenyl-butazone derivatives
JPS51115457A (en) 166methyll9 alphaa halosteroid derivatives
GB1486646A (en) Thieno-pyridine derivatives
AU8162975A (en) Benzazine derivatives